Drug Type siRNA |
Synonyms |
Target |
Mechanism lipoprotein(a) inhibitors, RNA interference |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Phase 3 | AU | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | IN | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | JP | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | DE | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | CN | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | AT | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | TW | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | FR | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | US | 05 Mar 2024 | |
Atherosclerosis | Phase 3 | DK | 05 Mar 2024 |